New MS diagnostic criteria put to the test in Real-World study
NCT ID NCT07492667
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares the 2024 and 2017 McDonald criteria for diagnosing multiple sclerosis (MS) in 100 patients with symptoms suggestive of MS. Researchers will see if the newer criteria catch more cases early without extra tests. The goal is to improve diagnosis and guide future updates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors diagnose multiple sclerosis earlier and more accurately using the latest criteria.
- What could go wrong
- This is an observational study, not a treatment trial. It may not change practice if the new criteria don't prove clearly better in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EVENT SUGGESTIVE OF MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Régional Universitaire
RECRUITINGNancy, Lorraine, F-54000, France
-
Centre Hospitalier Régional de Metz, site Mercy
RECRUITINGArs-Laquenexy, Lorraine, F-57530, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?